LL-37 Antimicrobial Peptide: Research Overview | telos rx
woman doing weight lifting
← Back to blog
antimicrobial

LL-37 Antimicrobial Peptide: Research Overview

By TelosRX Editorial Team Updated

LL-37 is the only human cathelicidin antimicrobial peptide and is studied in immune and antimicrobial research. This page is an educational overview. telos rx does not offer or prescribe LL-37.

What Is LL-37?

LL-37 is a 37-amino-acid peptide derived from human cathelicidin. It is studied in preclinical research for antimicrobial and immune-modulating pathways.

LL-37 is not an FDA-approved drug.

Where LL-37 Shows Up in Research

LL-37 comes up most often in research on:

  • Antimicrobial pathways
  • Immune modulation
  • Skin and barrier function
  • Inflammation

Most of this work is laboratory and animal research, so the human evidence is limited.

Regulatory Context

LL-37 is not FDA-approved. It was not among the peptides reviewed by the FDA's Pharmacy Compounding Advisory Committee in July 2026, and it is not covered by the interim enforcement discretion policy HHS announced on October 28, 2026, which applies only to BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500.

Does telos rx Offer LL-37?

No. telos rx does not offer, prescribe or ship LL-37.

Important Information

LL-37 is not FDA-approved. This article is for education only and is not medical advice.

Want to read more? Browse our Peptide Research blog.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX